Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder

NCT00107926 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.

NCT NCT00107926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00107926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder
Lead sponsor
Novartis Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2004
Completion date
August 31, 2007
Enrollment
343 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder